Caricamento...
Cyclin‐dependent kinase (CDK) inhibitors for hormone receptor‐positive advanced breast cancer
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of cyclin‐dependent kinase (CDK) 4/6 inhibitors in the treatment of patients with hormone receptor‐positive advanced breast cancer.
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6491121/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012919 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|